NCT00029614View on ClinicalTrials.gov

Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2006

Study Completion Date

July 31, 2007

Conditions
Substance Use DisordersAttention Deficit Hyperactivity Disorder
Interventions
DRUG

Atomoxetine

Trial Locations (1)

15213

Western Psychiatric Institute and Clinic, Pittsburgh

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

University of Pittsburgh

OTHER

NCT00029614 - Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD | Biotech Hunter | Biotech Hunter